{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:01:26Z","timestamp":1768870886717,"version":"3.49.0"},"reference-count":3,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.pnpbp.2009.04.006","type":"journal-article","created":{"date-parts":[[2009,4,18]],"date-time":"2009-04-18T08:49:27Z","timestamp":1240044567000},"page":"908-909","source":"Crossref","is-referenced-by-count":11,"title":["Perazine elevates clozapine serum levels by inhibiting hepatic metabolism"],"prefix":"10.1016","volume":"33","author":[{"given":"Gerd","family":"Schaller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Jacobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Rotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Kornhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hillemacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pnpbp.2009.04.006_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/138920007780655469","article-title":"CYP-mediated clozapin interactions: how predictable are they?","volume":"8","author":"Chetty","year":"2007","journal-title":"Curr Drug Metab"},{"issue":"4","key":"10.1016\/j.pnpbp.2009.04.006_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s002130000489","article-title":"Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro","volume":"151","author":"Str\u00f6mer","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"issue":"6","key":"10.1016\/j.pnpbp.2009.04.006_bib3","first-page":"615","article-title":"Effects of phenothiazine neuroleptics on the rate of caffein demethylation and hydroxylation in the rat liver","volume":"53","author":"Daniel","year":"2001","journal-title":"Pol J Pharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T11:25:45Z","timestamp":1545305145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584609001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":3,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0278584609001225"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2009.04.006","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}